Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
iloprost (ventavis) (2 trials)
Neoplasm Metastasis (Phase 3)
Raynaud Disease (Phase 3)
Scleroderma, Diffuse (Phase 3)
Scleroderma, Systemic (Phase 3)
Sclerosis (Phase 3)
Trials (2 total)
Trial APIs (1 total)